SCHEMBL5170741

SCHEMBL5170741

O=C(O)C1(I)CCCCN1S(=O)(=O)c1cccc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
TSHR P16473 3/20 0.43
PKM P14618 1/20 0.43
USP2 O75604 5/20 0.43
ALDH1A1 P00352 4/20 0.43
CYP2C9 P11712 3/20 0.43
HIF1A Q16665 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 2/20 0.42
CYP2D6 P10635 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP3A4 P08684 2/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41
IL1RN P18510 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
GPR183 P32249 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5171066 1.00 MEN1 (0.46) MEN1KMT2ATSHRPKMUSP2
SCHEMBL5169319 0.85 KMT2A (0.48) MEN1KMT2APKMALDH1A1SMN1; SMN2
SCHEMBL5173406 0.82 L3MBTL1 (0.47) TSHRPKMUSP2ALDH1A1MAPT
SCHEMBL14489550 0.71 ALDH1A1 (0.69) MEN1KMT2ATSHRPKMALDH1A1
SCHEMBL6368338 0.70 PKM (0.41) MEN1KMT2APKMALDH1A1SMN1; SMN2
SCHEMBL31684030 0.70 ALDH1A1 (0.67) MEN1KMT2ATSHRPKMUSP2
SCHEMBL4555427 0.70 ALDH1A1 (0.67) MEN1KMT2ATSHRPKMUSP2
SCHEMBL28308929 0.70 ALDH1A1 (0.67) MEN1KMT2ATSHRPKMUSP2
SCHEMBL2701162 0.69 KMT2A (0.76) MEN1KMT2ATSHRPKMUSP2
SCHEMBL630205 0.68 ALDH1A1 (0.57) MEN1KMT2ATSHRPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP claimed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed